Latest Breaking News On - Bridgebio pharma inc - Page 11 : comparemela.com

BridgeBio Pharma Inc (BBIO) Reports Q4 and Full Year 2023 Financials, Advances Key Clinical Trials

Strategic Partnerships and Capital Infusion Position BBIO for ATTR-CM Treatment Launch

BridgeBio Pharma: Q4 Earnings Snapshot

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $168.1 million in its fourth quarter.

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Acquired by Covestor Ltd

Covestor Ltd raised its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 131.5% in the third quarter, Holdings Channel.com reports. The fund owned 9,587 shares of the company’s stock after acquiring an additional 5,446 shares during the period. Covestor Ltd’s holdings in BridgeBio Pharma were worth $252,000 at the end of the most […]

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $42.00 Average Price Target from Brokerages

BBIO240223P00036000 (BBIO240223P00036000) Stock Price, News, Quote & History

Find the latest BBIO240223P00036000 (BBIO240223P00036000) stock quote, history, news and other vital information to help you with your stock trading and investing.